• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Lunglife Ai, INC (LLA)

ORD SHS USD0.0001 (DI) (REG S, CAT 3)
Sell: 4.00p|Buy: 10.00p|Change: 1.50 (27.27%)

Open 

7.00p

Previous close 

5.50p

Trade high 

1.00p

Volume 

57,369

Year high 

20.00p

Year low 

1.00p

Dividend yield 

–

Market capitalisation 

£2.15 mn

P/E ratio 

–

ISIN 

USU5500L1128

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 28/04/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Lunglife Ai, INC 0.00
More...

Company profile

LungLife AI Inc is focused on a developing clinical diagnostic solutions for lung cancer. The Company generates revenue from People's Republic of China and also has its presence in the United States of America.

Sector 

Healthcare

News

Recent trades

DateTimePriceQuantityValue (£)
12/02/202504:29:09157,369573.69

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.